Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31472046)

  • 1. Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
    Cao G; Xie Y; Jiang X; Tian X; Wang D; Sun Y
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):44-51. PubMed ID: 31472046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgery.
    Zhong Y; Zhou Q; Zhang Y; Zhou S; Zhang G; Jiang C; Zhang Z; Zhang X; Xu J; Jin C; Cao L; Chen L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):135-141. PubMed ID: 32415940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
    Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum cfDNA concentration and integrity before and after surgery in patients with lung cancer.
    Fan Y; Shi M; Chen S; Ju G; Chen L; Lu H; Chen J; Zheng S
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):56-63. PubMed ID: 31472048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of plasma cfDNA concentration and integrity in breast cancer patients.
    Miao Y; Fan Y; Zhang L; Ma T; Li R
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):64-72. PubMed ID: 31472049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.
    Yu D; An G; Xu L
    Clin Lab; 2016 Oct; 62(10):1947-1953. PubMed ID: 28164530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
    Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
    Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
    Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
    Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma.
    Eskander NS; Mansour L; Abdelaal A; Saad E; Mohamed D
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):339-348. PubMed ID: 35092403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
    Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
    Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
    Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer.
    Wu Z; Yu L; Hou J; Cui L; Huang Y; Chen Q; Sun Y; Lu W; Zhang C; Sun D
    J Oncol; 2022; 2022():9538384. PubMed ID: 35685424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of cell-free DNA in gastrointestinal tract malignancy.
    Lan YT; Chen MH; Fang WL; Hsieh CC; Lin CH; Jhang FY; Yang SH; Lin JK; Chen WS; Jiang JK; Lin PC; Chang SC
    Oncotarget; 2017 Jan; 8(2):3009-3017. PubMed ID: 27936467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stage-dependent alterations in cell-free DNA in patients with colorectal cancer.
    Pu W; Xiao L; Zhou C; Zhong F; Wu Y; Gong W; Lv X; Zhuang Z; Wang H; Bian H; Wang J; Zhang R; Li K; Xing C
    J BUON; 2021; 26(1):109-115. PubMed ID: 33721440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
    Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
    Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
    Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
    Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring].
    Fan P; Zhang Y; Deng F; Chen SH; Li M; Zhang Q
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2670-2673. PubMed ID: 28910954
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients.
    Ye HM; Lu YZ; Liang XM; Lin YZ; Li Y; Zhang ZY; Tzeng CM
    Clin Lab; 2014; 60(3):397-405. PubMed ID: 24697115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.